Research and innovation

Is searching and developing innovative and proprietary pharmaceutical products designed to better manage cardiometabolic disorders is Acasti’s main focus.

Read more

Our products

Currently, Acasti has a leading prescription drug candidate, CaPre®

Read more

About Acasti

Acasti Pharma Inc. is an emerging biopharmaceutical company dedicated to the research, development and commercialization of innovative proprietary pharmaceuticals for the management of cardiometabolic disorders, from prevention to treatment, through a novel superior approach to lipid regulation.

Read more

News

Find the latest articles and news about us! Find out about our recent announcements and quarterly results.

Read more